Volpara Health Technologies Ltd
VHT.AU
| Exchange: | AU |
| Currency | Australian Dollar |
| Open Figi: | BBG00B2MGNB4 |
| ISIN: | NZVHTE0001S6 |
| Fiscal Year End: | March |
| International Domestic: | International |
| Sector: | Healthcare |
| Industry: | Health Information Services |
| Gic Sector: | Health Care |
| Gic Group: | Health Care Equipment & Services |
| Gic Industry: | Health Care Technology |
| Gic Sub Industry: | Health Care Technology |
| Description: | Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters. In addition, the company provides Tru Density, a Volpara clinical function; Tru PGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; Tru Pressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and Tru Rad Dose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with Reveal Dx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand. As of May 13, 2024, Volpara Health Technologies Limited operates as a subsidiary of Lunit Inc.. |
| Address: | 40 Mercer Street, Wellington, New Zealand, 6011 |
| Website: | https://www.volparahealth.com |
| Full Time Employees: | 156 |
| Updated On: | 2024-06-21 |
Highlights
| Market Capitalization: | 291258240 |
| Market Capitalization Mln: | 291.25 |
| EBITDA: | -7897000 |
| Wall Street Target Price: | 0.95 |
| Book Value: | 0.18 |
| Earnings Share: | -0.04 |
| EPS Estimate Current Year: | -0.01 |
| Most Recent Quarter: | 2023-09-30 |
| Profit Margin: | -0.23 |
| Operating Margin TTM: | -0.24 |
| Return On Assets TTM: | -0.07 |
| Return On Equity TTM: | -0.17 |
| Revenue TTM: | 37963000 |
| Revenue Per Share TTM: | 0.15 |
| Quarterly Revenue Growth YOY: | 0.17 |
| Gross Profit TTM: | 23823000 |
| Diluted Eps TTM: | -0.04 |
Valuation
| Price Sales TTM: | 7.65 |
| Price Book MRQ: | 6.52 |
| Enterprise Value: | 279398592 |
| Enterprise Value Revenue: | 7.78 |
| Enterprise Value Ebitda: | -60.98 |
Shares
| Shares Outstanding: | 254374000 |
| Shares Float: | 192932738 |
| Percent Insiders: | 25.03 |
| Percent Institutions: | 20.50 |
Technicals
| Beta: | 1.66 |
| 52 Week High: | 1.15 |
| 52 Week Low: | 1.12 |
| 50 Day MA: | 1.13 |
| 200 Day MA: | 0.95 |
Holders
| Name: | SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF |
| Date: | 2021-02-28 |
| Total Shares: | 0.02 |
| Current Shares: | 5881 |
Earnings
| Report Date: | 2023-11-21 |
| Date: | 2023-09-30 |
| Before After Market: | Before Market |
| Currency: | AUD |
| Report Date: | 2023-07-21 |
| Date: | 2023-06-30 |
| Before After Market: | Before Market |
| Currency: | AUD |
| Report Date: | 2023-05-25 |
| Date: | 2023-03-31 |
| Before After Market: | Before Market |
| Currency: | AUD |
| Eps Estimate: | -0.03 |
| Eps Difference: | 0.03 |
| Surprise Percent: | 10 |
| Report Date: | 2023-01-18 |
| Date: | 2022-12-31 |
| Before After Market: | Before Market |
| Currency: | AUD |
| Report Date: | 2022-11-23 |
| Date: | 2022-09-30 |
| Before After Market: | Before Market |
| Currency: | AUD |
| Report Date: | 2022-08-31 |
| Date: | 2022-06-30 |
| Currency: | AUD |
| Report Date: | 2022-05-25 |
| Date: | 2022-03-31 |
| Currency: | AUD |
| Report Date: | 2022-03-02 |
| Date: | 2021-12-31 |
| Currency: | AUD |
| Report Date: | 2021-11-22 |
| Date: | 2021-09-30 |
| Currency: | AUD |
| Report Date: | 2021-09-01 |
| Date: | 2021-06-30 |
| Currency: | AUD |
| Report Date: | 2021-05-26 |
| Date: | 2021-03-31 |
| Currency: | AUD |
| Report Date: | 2021-03-03 |
| Date: | 2020-12-31 |
| Currency: | AUD |
| Report Date: | 2020-11-24 |
| Date: | 2020-09-30 |
| Currency: | AUD |
| Report Date: | 2018-06-29 |
| Date: | 2018-03-31 |
| Currency: | AUD |
| Eps Actual: | -0.03 |
| Eps Difference: | -0.03 |
| Report Date: | 2017-11-09 |
| Date: | 2017-09-30 |
| Currency: | AUD |
| Eps Actual: | -0.03 |
| Eps Difference: | -0.03 |
| Report Date: | 2017-05-29 |
| Date: | 2017-03-31 |
| Currency: | AUD |
| Eps Actual: | -0.04 |
| Eps Difference: | -0.04 |
| Report Date: | 2016-11-14 |
| Date: | 2016-09-30 |
| Currency: | AUD |
| Eps Actual: | -0.04 |
| Eps Difference: | -0.04 |
| Report Date: | 2016-04-26 |
| Date: | 2016-03-31 |
| Before After Market: | After Market |
| Currency: | AUD |
| Eps Actual: | -0.23 |
| Eps Difference: | -0.23 |
| Date: | 2026-03-31 |
| Period: | +1y |
| Growth: | 1.00 |
| Earnings Estimate Low: | -0.02 |
| Earnings Estimate High: | 0.01 |
| Earnings Estimate Year Ago Eps: | -0.01 |
| Earnings Estimate Number Of Analysts: | 2.00 |
| Earnings Estimate Growth: | 1.00 |
| Revenue Estimate Avg: | 52630000.00 |
| Revenue Estimate Low: | 49750000.00 |
| Revenue Estimate High: | 55500000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.18 |
| Eps Trend30days Ago: | 0.02 |
| Eps Trend60days Ago: | 0.02 |
| Eps Trend90days Ago: | 0.02 |
| Date: | 2025-03-31 |
| Earnings Estimate Avg: | -0.01 |
| Earnings Estimate Low: | -0.03 |
| Earnings Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Avg: | 44600000.00 |
| Revenue Estimate Low: | 43000000.00 |
| Revenue Estimate High: | 46200000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.04 |
| Eps Trend Current: | -0.01 |
| Eps Trend7days Ago: | -0.01 |
| Eps Trend30days Ago: | -0.01 |
| Eps Trend60days Ago: | -0.01 |
| Eps Trend90days Ago: | -0.01 |
| Date: | 2024-06-30 |
| Period: | +1q |
| Date: | 2024-03-31 |
| Growth: | 0.25 |
| Earnings Estimate Avg: | -0.03 |
| Earnings Estimate Low: | -0.04 |
| Earnings Estimate High: | -0.02 |
| Earnings Estimate Year Ago Eps: | -0.04 |
| Earnings Estimate Number Of Analysts: | 2.00 |
| Earnings Estimate Growth: | 0.25 |
| Revenue Estimate Avg: | 37150000.00 |
| Revenue Estimate Low: | 35010000.00 |
| Revenue Estimate High: | 39300000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.15 |
| Eps Trend Current: | -0.03 |
| Eps Trend7days Ago: | -0.03 |
| Eps Trend30days Ago: | -0.02 |
| Eps Trend60days Ago: | -0.03 |
| Eps Trend90days Ago: | -0.03 |
| Date: | 2023-12-31 |
| Date: | 2023-09-30 |
| Date: | 2023-06-30 |
| Revenue Estimate Growth: | 0.37 |
| Date: | 2023-03-31 |
| Growth: | 0.57 |
| Earnings Estimate Avg: | -0.03 |
| Earnings Estimate Low: | -0.04 |
| Earnings Estimate High: | -0.02 |
| Earnings Estimate Year Ago Eps: | -0.07 |
| Earnings Estimate Number Of Analysts: | 2.00 |
| Earnings Estimate Growth: | 0.57 |
| Revenue Estimate Avg: | 32690000.00 |
| Revenue Estimate Low: | 31890000.00 |
| Revenue Estimate High: | 33500000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.38 |
| Eps Trend Current: | -0.03 |
| Eps Trend7days Ago: | -0.03 |
| Eps Trend30days Ago: | -0.03 |
| Eps Trend60days Ago: | -0.03 |
| Eps Trend90days Ago: | -0.03 |
| Date: | 2022-12-31 |
| Date: | 2022-09-30 |
| Date: | 2022-06-30 |
| Period: | +1q |
| Date: | 2022-03-31 |
| Revenue Estimate Avg: | 30880000.00 |
| Revenue Estimate Low: | 28940000.00 |
| Revenue Estimate High: | 32860000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.31 |
| Date: | 2020-03-31 |
| Period: | +1y |
| Revenue Estimate Avg: | 17960000.00 |
| Revenue Estimate Low: | 15740000.00 |
| Revenue Estimate High: | 20180000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 1.49 |
| Eps Trend7days Ago: | -0.01 |
| Eps Trend30days Ago: | -0.01 |
| Eps Trend60days Ago: | -0.01 |
| Eps Trend90days Ago: | -0.01 |
| Date: | 2019-09-30 |
| Period: | +1q |
| Revenue Estimate Avg: | 7200000.00 |
| Revenue Estimate Low: | 6500000.00 |
| Revenue Estimate High: | 7900000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 1.78 |
| Date: | 2019-06-30 |
| Revenue Estimate Avg: | 7200000.00 |
| Revenue Estimate Low: | 6500000.00 |
| Revenue Estimate High: | 7900000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 1.78 |
| Date: | 2019-03-31 |
| Revenue Estimate Avg: | 7200000.00 |
| Revenue Estimate Low: | 6500000.00 |
| Revenue Estimate High: | 7900000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 1.78 |
| Eps Trend7days Ago: | -0.06 |
| Eps Trend30days Ago: | -0.06 |
| Eps Trend60days Ago: | -0.06 |
| Eps Trend90days Ago: | -0.06 |
| Date: | 2023-09-30 |
| Date: | 2023-03-31 |
| Date: | 2022-03-31 |
| Date: | 2021-03-31 |
| Date: | 2018-03-31 |
| Eps Actual: | -0.0 |
| Date: | 2017-03-31 |
| Eps Actual: | -0.0 |
| Date: | 2016-03-31 |
| Eps Actual: | -0.2 |